Galectin Therapeutics Inc.
GALT •
Sell Open
Signal type
Sell
Status
Open
Open Price
$2.56
Stop Loss
$2.99
Performance
3.52%
Days Open
16
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 30, 2026
Open Price $2.56
Stop Loss $2.99
Timespan Day
Company Profile
Name Galectin Therapeutics Inc.
Ticker GALT
Market Cap $137.34M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $2.47
List Date Sep 4, 2002
Description
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Website Open Company Website